OPALEYE MANAGEMENT INC. sold 70.4% of their position (126.69K shares) of ETON PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $4.77M — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
Common Stock, par value $0.001 per share
Shares
−65K
Price / share
$37.39
Trade value
$2.43M
% of position
Common Stock, par value $0.001 per share
Shares
−25K
Price / share
$37.39
Trade value
$934.63K
% of position
Common Stock, par value $0.001 per share
Shares
−10K
Price / share
$38.00
Trade value
$380K
% of position
Common Stock, par value $0.001 per share
Shares
−20K
Price / share
$38.37
Trade value
$767.46K
% of position
Common Stock, par value $0.001 per share
Shares
−6.68K
Price / share
$38.37
Trade value
$256.52K
% of position
Net shares
−126.69K
Net value
-$4.77M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock, par value $0.001 per share Indirect | 7/2/2026 | S · Sale | −65K | $37.39 | $2.43M | 2.3% | 2.77M | 2.71M |
| Common Stock, par value $0.001 per share Indirect | 7/2/2026 | S · Sale | −25K | $37.39 | $934.63K | 29.4% | 85K | 60K |
| Common Stock, par value $0.001 per share Indirect | 7/6/2026 | S · Sale | −10K | $38.00 | $380K | 0.4% | 2.71M | 2.70M |
| Common Stock, par value $0.001 per share Indirect | 7/7/2026 | S · Sale | −20K | $38.37 | $767.46K | 0.7% | 2.70M | 2.68M |
| Common Stock, par value $0.001 per share Indirect | 7/7/2026 | S · Sale | −6.68K | $38.37 | $256.52K | 11.1% | 60K | 53.31K |
| Total | −126.69K | -$4.77M | ||||||